Search Results - "Hirmerova, J"

The association of factor V Leiden with various clinical patterns of venous thromboembolism-the factor V Leiden paradox by Hirmerova, J, Seidlerova, J, Subrt, I

“…Factor V Leiden (FVL) supposedly carries relatively higher risk of deep vein thrombosis (DVT), compared to the risk of pulmonary embolism (PE). To prove this…”
Get full text

Deep vein thrombosis and/or pulmonary embolism concurrent with superficial vein thrombosis of the legs: cross-sectional single center study of prevalence and risk factors by Hirmerova, J, Seidlerova, J, Subrt, I

“…The aim of this paper was to assess the prevalence of concurrent deep vein thrombosis (DVT) and/or pulmonary embolism (PE) in the patients with superficial…”
Get more information

Risk factors for residual thrombotic occlusion after proximal deep vein thrombosis of the legs by Hirmerova, J, Seidlerova, J, Filipovsky, J

“…Residual thrombotic occlusion (RTO) after deep vein thrombosis (DVT) is considered as a risk factor of recurrent venous thromboembolism (VTE). We searched for…”
Get more information

Laboratory evaluation of antiphospholipid antibodies in patients with venous thromboembolism by Hirmerova, J, Ulcova-Gallova, Z, Seidlerova, J, Filipovsky, J, Bibkova, K, Micanova, Z, Mayer, Jr, O

“…The objective of our study was to evaluate the significance of extended antiphospholipid profile in patients with venous thromboembolism without any systemic…”
Get more information

PB1448 Genetic Polymorphisms in Varicose Veins with and without Thrombosis by Hirmerova, J., Cerna, V., Cerna, M.

Get full text

Development of a Risk Prediction Score for Occult Cancer in Patients With VTE by Jara-Palomares, Luis, MD, PhD, Otero, Remedios, MD, PhD, Jimenez, David, PhD, Carrier, Marc, MD, Tzoran, Inna, MD, Brenner, Benjamin, MD, Margeli, Mireia, MD, Praena-Fernandez, Juan Manuel, PhD, Grandone, Elvira, MD, PhD, Monreal, Manuel, MD, PhD

“…Background The benefits of a diagnostic workup for occult cancer in patients with VTE are controversial. Our aim was to provide and validate a risk score for…”
Get full text

Treatment of Right Heart Thrombi Associated with Acute Pulmonary Embolism by Barrios, Deisy, MD, Chavant, Jeremy, MD, Jiménez, David, PhD, Bertoletti, Laurent, PhD, Rosa-Salazar, Vladimir, PhD, Muriel, Alfonso, PhD, Viallon, Alain, PhD, Fernández-Capitán, Carmen, PhD, Yusen, Roger D., MD, Monreal, Manuel, PhD

“…Abstract Background Evidence-based recommendations do not adequately address the treatment of right heart thrombi in patients who present with acute…”
Get full text

DVT Management and Outcome Trends, 2001 to 2014 by Morillo, Raquel, MD, Jiménez, David, PhD, Aibar, Miguel Ángel, MD, Mastroiacovo, Daniela, MD, Wells, Philip S., MD, Sampériz, Ángel, PhD, Saraiva de Sousa, Marta, MD, Muriel, Alfonso, PhD, Yusen, Roger D., MD, Monreal, Manuel, PhD

“…Background A comprehensive evaluation of temporal trends in the treatment of patients who have DVT may assist with identification of modifiable factors that…”
Get full text

Prophylaxis of thromboembolism yesterday, today, and tomorrow--editorial by Hirmerova, J

Get more information

Outcome of patients with venous thromboembolism and Factor V Leiden or Prothrombin 20210 carrier mutations during the course of anticoagulation by Tzoran, Inna, MD, Papadakis, Manolis, MD, Brenner, Benjamin, MD, Fidalgo, Ángeles, MD. PhD, Rivas, Agustina, MD, Wells, Philip S., MD, Gavín, Olga, MD. PhD, Adarraga, María Dolores, MD. PhD, Moustafa, Farès, MD, Monreal, Manuel, MD. Ph.D

“…Abstract Background Individuals with factor V Leiden or prothrombin G20210A mutations are at a higher risk to develop venous thromboembolism. However, the…”
Get full text

Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry by Golemi, Iva, Cote, Lauren, Iftikhar, Omer, Brenner, Benjamin, Bikdeli, Behnood, Fernández-Capitán, Carmen, Pedrajas, José María, Monreal, Manuel, Prandoni, Paolo, Barba, Raquel, Bounameaux, Henri, Malý, Radovan, Verhamme, Peter, Adarraga, M.D., Aibar, J., Amado, C., Azcarate, P.M., Ballaz, A., Barba, R., Barrón, M., Bascuñana, J., Blanco-Molina, A., Castro, J., de Ancos, C., del Toro, J., Demelo, P., Díaz-Simón, R., Fidalgo, M.A., Font, L., García-Morillo, M., García-Raso, A., Gavín, O., Gayol, M.C., Guirado, L., González-Martínez, J., Grau, E., Gutiérrez, J., Iglesias, M., Jara-Palomares, L., Jou, I., Llamas, P., Lobo, J.L., López-Nuñez, J.J., López-Reyes, R., Lorente, M.A., Lorenzo, A., Loring, M., Madridano, O., Maestre, A., Martín Fernández, M., Monreal, M., Morales, M.V., Nieto, J.A., Núñez, M.J., Olivares, M.C., Otalora, S., Pedrajas, J.M., Pellejero, G., Pérez-Rus, G., Rodríguez-Dávila, M.A., Rodríguez-Hernández, A., Rubio, C.M., Ruiz-Ruiz, J., Ruiz-Sada, P., Sahuquillo, J.C., Sánchez-Muñoz-Torrero, J.F., Sanoja, I., Soto, M.J., Suriñach, J.M., Torres, M.I., Trujillo-Santos, J., Vázquez, F.J., Vanassche, T., Salgado, E., Bertoletti, L., Bura-Riviere, A., Falvo, N., Hij, A., Brenner, B., Barillari, G., Bucherini, E., Ciammaichella, M., Di Micco, P., Grandone, E., Mumoli, N., Pace, F., Parisi, R., Pesavento, R., Pinelli, M., Quintavalla, R., Siniscalchi, C., Tufano, A., Skride, A., Sablinskis, K., Sablinskis, M., Zdraveska, M., Bounameaux, H., Ney, B., Mazzolai, L., Tafur, A.

“…Overlap exists between the risk factors for coronary artery disease and venous thromboembolism (VTE). However, a paucity of data is available on the incidence…”
Get full text

Analysis of noncatheter-associated upper extremity deep venous thrombosis from the RIETE registry by Newton, Daniel H., MD, Monreal Bosch, Manuel, MD, PhD, Amendola, Michael, MD, Wolfe, Luke, MS, Perez Ductor, Cristina, MD, Lecumberri, Ramón, MD, PhD, Levy, Mark M., MD

“…Abstract Objective We sought to determine the risk factors for subsequent bleeding and recurrent venous thromboembolism (VTE) events following isolated…”
Get full text

Superficial thrombophlebitis, unjustly underestimated disease - has the time come to change our view? by Hirmerová, J

“…Superficial thrombophlebites represent a very heterogeneous group of diseases which is caused by the difference between two basic forms of ST - varicophlebitis…”
Get more information

Percutaneous coronary intervention in a patient with immune thrombocytopenia purpura by Stouffer, George A., Hirmerova, Jana, Moll, Stephan, Rubery, Bryon, Napoli, Mark, Ohman, E. Magnus, Simpson, Ross

“…The appropriate regimen of platelet inhibitors that should be used in patients with immune thrombocytopenia purpura (ITP; formerly called idiopathic…”
Get full text

The optimum length of anticoagulation therapy after venous thromboembolism--universal or individualised approach? by Hirmerová, J

“…Long-term peroral anticoagulation treatment is indicated after a thromboembolic event. The length of treatment should be based on balancing the risk of…”
Get more information

The prophylaxis against venous thromboembolic complications in internal medicine--the gap between theory and practice by Hirmerová, J

“…Venous thromboembolism is an important cause of morbidity and mortality in internal medicine but antithrombotic prophylaxis is not being sufficiently used in…”
Get more information

Clinical importance of aspirin resistance by Hirmerová, J, Filipovský, J

“…The antiplatelet effect of aspirin is mostly explained by the irreversible cyclooxygenase-1 inhibition resulting in the suppression of thromboxane A2…”
Get more information

Long-term drug interaction of warfarin with amiodarone by Hirmerová, J, Suchý, D, Mádr, T

“…Authors describe a case of drug interaction between amiodarone and warfarin in 66-year-old man with recurrent atrial fibrillation. In spite of a relatively low…”
Get more information